Quoin Pharmaceuticals annual r&d spending
2017
2019
2020
2021
2022
2023
2024
2025
Quoin Pharmaceuticals R&D Spending Growth & History (QNRX)
Quoin Pharmaceuticals's r&d spending was $9.8M for fiscal 2025.
View full Quoin Pharmaceuticals company overviewQuoin Pharmaceuticals annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $9.8M | $6.2M | +172.10% |
| 2024 | 2024-12-31 | $3.6M | $294,645 | +8.91% |
| 2023 | 2023-12-31 | $3.3M | $635,151 | +23.76% |
| 2022 | 2022-12-31 | $2.7M | $1.1M | +71.01% |
| 2021 | 2021-12-31 | $1.6M | $1.3M | +540.14% |
| 2020 | 2020-12-31 | $244,155 | $198,505 | +434.84% |
| 2019 | 2019-12-31 | $45,650 | — | — |
| 2017 | 2017-12-31 | $3.3M | — | — |
Quoin Pharmaceuticals quarterly r&d spending
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $3.6M | $1.6M | +76.88% |
| Q1 2026 | 2026-03-31 | $3.4M | $1.1M | +44.63% |
| Q4 2025 | 2025-12-31 | $3.1M | $2.0M | +194.88% |
| Q3 2025 | 2025-09-30 | $2.3M | $1.2M | +111.29% |
| Q2 2025 | 2025-06-30 | $2.1M | $1.5M | +249.03% |
| Q1 2025 | 2025-03-31 | $2.4M | $1.5M | +168.17% |
| Q4 2024 | 2024-12-31 | $1.1M | $217,820 | +26.17% |
| Q3 2024 | 2024-09-30 | $1.1M | $320,861 | +42.29% |
| Q2 2024 | 2024-06-30 | $587,503 | −$37,601 | −6.02% |
| Q1 2024 | 2024-03-31 | $885,298 | −$206,435 | −18.91% |
| Q4 2023 | 2023-12-31 | $832,391 | $219,324 | +35.77% |
| Q3 2023 | 2023-09-30 | $758,759 | $13,253 | +1.78% |
| Q2 2023 | 2023-06-30 | $625,104 | −$101,590 | −13.98% |
| Q1 2023 | 2023-03-31 | $1.1M | $504,164 | +85.81% |
| Q4 2022 | 2022-12-31 | $613,067 | — | — |
| Q3 2022 | 2022-09-30 | $745,506 | $485,510 | +186.74% |
| Q2 2022 | 2022-06-30 | $726,694 | $487,414 | +203.70% |
| Q1 2022 | 2022-03-31 | $587,569 | — | — |
| Q3 2021 | 2021-09-30 | $259,996 | — | — |
| Q2 2021 | 2021-06-30 | $239,280 | — | — |
Quoin Pharmaceuticals r&d spending trends
Over the last five fiscal years, Quoin Pharmaceuticals's r&d spending increased from $244,155 to $9.8M, a change of $9.6M. The latest reported quarter, Q2 2026, shows $3.6M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Quoin Pharmaceuticals source filings ↗